| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Jun―11 |
An epidemiological study of multisystem inflammatory syndrome in children (MIS-C) and young adults among COVID-19-positive patients - data from National Inpatient Sample database |
Shruti Aggarwal, Jasninder Singh Dhaliwal, Nomesh Kumar, Hemamalini Sakthivel, Raheel Ahmed, Renuka Verma, Kamleshun Ramphul |
| 2 |
[GO] |
2024―Mar―18 |
COVID-19 prophylaxis, diagnostics, and treatment in patients with rheumatic diseases. The Polish experts panel opinion |
Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko, Maria Maślińska, Marcin Stajszczyk, Jerzy Świerkot, Piotr Wiland, Zbigniew Żuber, Krzysztof Tomasiewicz |
| 3 |
[GO] |
2024―Mar―18 |
Autoimmune rheumatic diseases and COVID-19 vaccination: a retrospective cross-sectional study from Astana |
Kristina Rutskaya-Moroshan, Saule Abisheva, Madina Sarsenova, Vyacheslav Ogay, Tatyana Vinnik, Bakyt Aubakirova, Anilim Аbіsheva |
| 4 |
[GO] |
2024―Mar―07 |
Symptom intensity of post-COVID and long COVID syndromes
in patients entering rehabilitation treatment |
Jan Ceklarz |
| 5 |
[GO] |
2024―Jan―22 |
Autoimmunity and long COVID in children |
Oksana Boyarchuk, Liubov Volianska |
| 6 |
[GO] |
2023―Oct―31 |
Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following immunisation with COVID-19 vaccines: a 15 months update |
Ciro Manzo, Alberto Castagna, Arvind Nune, Marco Isetta |
| 7 |
[GO] |
2023―Jul―19 |
Influenza - a problem still existing during the COVID-19 pandemic |
Lidia Brydak |
| 8 |
[GO] |
2023―Jul―19 |
Emotional and cognitive states of geriatric patients during the COVID-19 pandemic - an observational study |
Teresa Sadura-Sieklucka, Joanna Szczuka, Tomasz Targowski |
| 9 |
[GO] |
2023―Mar―08 |
Overlapping clinical features of systemic juvenile idiopathic arthritis and SARS-CoV-2-related multisystem inflammatory syndrome in children |
Oksana Boyarchuk, Tetiana Kovalchuk |
| 10 |
[GO] |
2022―Sep―09 |
Influence of biologic and conventional disease-modifying antirheumatic drugs on COVID-19 incidence among rheumatic patients during the first and second wave of the pandemic in Iran |
Maryam Sahebari, Zahra Mirfeizi, Zhaleh Shariati-Sarabi, Malihe Moghadam, Kamila Hashemzadeh, Mona Firoozabadi |
| 11 |
[GO] |
2022―May―18 |
Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literature |
Ciro Manzo, Alberto Castagna, Marco Isetta |
| 12 |
[GO] |
2022―May―18 |
May IgG4-related disease be reactivated by SARS-CoV-2 infection? |
Senol Kobak |
| 13 |
[GO] |
2022―May―18 |
Prophylaxis of occipital pressure sores in patients after elective spinal surgery in a pandemic condition |
Piotr Tederko, Victoria Perovic-Kaczmarek, Robert Gasik, Beata Tarnacka |
| 14 |
[GO] |
2022―Jan―12 |
The course of COVID-19 in patients with Behçet’s disease |
Ayse Enginar, Mustafa Gundogdu |
| 15 |
[GO] |
2021―Dec―22 |
COVID-19 vaccination-associated anti-Jo-1 syndrome |
Kushagra Gupta, Gauri Shankar Sharma, Ashok Kumar |
| 16 |
[GO] |
2021―Sep―15 |
COVID-19 in patients with juvenile idiopathic arthritis: frequency and severity |
Oksana Boyarchuk, Lilya Predyk, Iryna Yuryk |
| 17 |
[GO] |
2021―Sep―15 |
COVID-19 - rheumatic diseases and rheumatologists |
Maria Maślińska |
| 18 |
[GO] |
2021―Sep―15 |
Challenges of Egyptian patients with systemic lupus erythematosus during the COVID-19 pandemic |
Samar Tharwat, Sherin Zohdy Mohamed, Mohammed Kamal Nassar |
| 19 |
[GO] |
2021―Sep―15 |
Update on COVID-19 vaccines and autoimmune-mediated rheumatic diseases |
Lakshmanan Suresh |
| 20 |
[GO] |
2021―Sep―15 |
Use of the rheumatic drug tocilizumab for treatment of SARS-CoV-2 patients |
Bogna Grygiel-Górniak, Osama Shaikh, Nikita Niranjan Kumar, Shao Heng Hsu, Włodzimierz Samborski |
| 21 |
[GO] |
2021―Apr―30 |
The impact of COVID-19 and healthcare system changes on the well-being of rheumatic patients |
Aleksandra Opinc, Olga Brzezińska, Joanna Makowska |
| 22 |
[GO] |
2021―Mar―10 |
Smart homes for the older population: particularly important during the COVID-19 outbreak |
Karolina Gawrońska, Jacek Lorkowski |
| 23 |
[GO] |
2021―Mar―10 |
Between COVID-19 severity and its prevention - what should rheumatologists be aware of? |
Joanna Makowska, Filip Styrzyński |
| 24 |
[GO] |
2020―Nov―16 |
Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19 |
Carlo Perricone, Elena Bartoloni, Roberto Gerli |
| 25 |
[GO] |
2020―Sep―16 |
Hygiene - gold standard not only in prevention of COVID-19 infection |
Barbara Nieradko-Iwanicka |
| 26 |
[GO] |
2020―Sep―16 |
Rheumatological aspects of pathogenesis and treatment of COVID-19 infection |
Desislava Kalinova, Rasho Rashkov |
| 27 |
[GO] |
2020―Jul―14 |
The attitude of Polish rheumatology patients towards telemedicine in the age of the COVID-19 pandemic |
Aleksandra Opinc, Zuzanna Łukasik, Joanna Makowska |
| 28 |
[GO] |
2020―Jul―14 |
COVID-19: a short message to rheumatologists |
Piotr Leszczyński |
